Paper32007108
Intensive care unit outcomes following orthotopic liver transplantation: single-center experience and review of the literature.
Damaskos C and 13 others. G Chir, 2019. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Intensive care unit outcomes following orthotopic liver transplantation: single-center experience and review of the literature. Papers, record 32007108. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32007108
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Intensive care unit outcomes following orthotopic liver transplantation: single-center experience and review of the literature.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Intensive Care Units | Major topic |
| Liver Transplantation | Major topic |
| Acute Kidney Injury | |
| Biliary Tract Diseases | |
| Female | |
| Graft Rejection | |
| Hepatic Artery | |
| Humans | |
| Immunosuppressive Agents | |
| Infections | |
| Male | |
| Middle Aged | |
| Nervous System Diseases | |
| Organ Size | |
| Postoperative Complications | |
| Primary Graft Dysfunction | |
| Respiration, Artificial | |
| Thrombosis | |
| Transplantation Conditioning | |
| Treatment Outcome |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40285684 | The role of rehabilitation across the continuum of liver disease from cirrhosis to transplantation and beyond: A narrative review. | PM R | 2025 | https://conductscience.org/library/papers/40285684 | PubMed |
| 40276743 | A nomogram for predicting early bacterial infection after liver transplantation: a retrospective study. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40276743 | PubMed |
| 37375682 | From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients. | Nutrients | 2023 | https://conductscience.org/library/papers/37375682 | PubMed |
| 36769004 | FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far? | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36769004 | PubMed |
| 36645610 | The Effects of the Spiritual Well-Being Levels of Surgical Nurses on Care Satisfaction in Liver Transplant Recipients After Transplantation: The Case of a Turkish Sample. | J Relig Health | 2024 | https://conductscience.org/library/papers/36645610 | PubMed |
| 36430594 | Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead-A Systematic Review. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430594 | PubMed |
| 36399311 | Association of different central venous pressure levels with outcome of living-donor liver transplantation in children under 12 years. | World J Pediatr | 2023 | https://conductscience.org/library/papers/36399311 | PubMed |
| 36032630 | Liver Transplantation and Budd-Chiari Syndrome: When the Cause Becomes the Solution. | Maedica (Bucur) | 2022 | https://conductscience.org/library/papers/36032630 | PubMed |
| 35629174 | The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma. | J Pers Med | 2022 | https://conductscience.org/library/papers/35629174 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32007108
GET https://conductscience.org/api/papers/v1/32007108/authors